Related Experiment Video

Updated: Dec 31, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.5K

Tankyrase inhibition sensitizes cells to CDK4 blockade

Miguel Foronda1, Yusuke Tarumoto2, Emma M Schatoff1,3

  • 1Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, United States of America.

Plos One
|January 1, 2020
PubMed

Insights

Combining tankyrase (TNKS) inhibitors with CDK4 blockade shows promise for epithelial tumors. This dual inhibition halts cancer cell proliferation by inducing cell cycle arrest and senescence, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Tankyrase (TNKS) 1/2 regulate WNT signaling, a pathway often hyperactive in tumors.
  • TNKS inhibitors can suppress WNT signaling but have limited anti-proliferative effects as monotherapy.
  • Identifying effective drug combinations is crucial for enhancing TNKS inhibitor efficacy.

Purpose of the Study:

  • To identify effective drug combinations with TNKS inhibitors using a kinome-focused CRISPR screen.
  • To investigate the synergistic effects of TNKS inhibition with other targeted therapies.
  • To evaluate the therapeutic potential of combined WNT and CDK4 inhibition in epithelial cancers.

Main Methods:

  • A kinome-focused CRISPR screen was employed to identify genetic modifiers of TNKS inhibitor sensitivity.
  • Cytidine base editors were used to model cancer-associated mutations.
  • The anti-proliferative effects and cell cycle impact of combined inhibition were assessed in human cancer cell lines.

Main Results:

  • Loss of CDK4, but not CDK6, synergizes with TNKS1/2 inhibition.
  • Combined TNKS and CDK4 blockade induces G1 cell cycle arrest and senescence.
  • This therapeutic approach is dependent on WNT signaling suppression and effective across multiple epithelial cancer types.

Conclusions:

  • Combined WNT and CDK4 inhibition represents a potential therapeutic strategy for epithelial tumors.
  • This combination overcomes the limitations of TNKS inhibitors as monotherapy.
  • The findings support further investigation of this dual-targeting approach in clinical settings.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K
Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

355

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K